Safety of PPAR Agonists-Reference-Cited by-同舟云学术

Safety of PPAR Agonists

Published:2011-04-22 Issue:Supplement_2 Volume:34 Page:S215-S219
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Home Philip¹

Affiliation:

1. Newcastle University and Newcastle Diabetes Centre, Institute of Cellular Medicine (Diabetes), The Medical School, Newcastle upon Tyne, U.K.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/34/Supplement_2/S215/609331/s215.pdf

Reference30 articles.

1. Peroxisome proliferator-activated receptor agonists;Willson;Curr Opin Chem Biol,1997

2. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003;Nesto;Circulation,2003

3. Takeda Global Research and Development Centre (Europe) Ltd. Actos: summary of product characteristics [Internet], 2005. Available from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000285/WC500021379.pdf. Accessed 9 March 2011

4. SmithKline Beecham. Avandia: summary of product characteristics [Internet], 2006. Available from http://www.ema.europa.eu. Accessed 19 June 2007

5. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy;Kahn;N Engl J Med,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria;eBioMedicine;2023-04

2. Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials;Cardiovascular Diabetology;2023-03-19

3. Transcriptional regulation profiling reveals PPARA-mediated fatty acid oxidation as a novel therapeutic target in phospholamban R14del cardiomyopathy;2022-10-28

4. KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD;American Journal of Kidney Diseases;2022-04

5. The Gut-Lung Axis in Cystic Fibrosis;Journal of Bacteriology;2021-09-23